Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PROKR2 | Q8NFJ6 | 5/20 | 0.70 |
| ▸ | MTNR1A | P48039 | 4/20 | 0.35 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.33 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.33 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.33 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.30 |
| ▸ | TAB1 | Q15750 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | ACKR3 | P25106 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL564206 | 0.93 | PROKR2 (0.75) | PROKR2MTNR1AMAPK8ROCK2ROCK1 | |
| SCHEMBL565621 | 0.91 | PROKR2 (0.72) | PROKR2MTNR1AMAPK8ROCK2ROCK1 | |
| SCHEMBL565414 | 0.89 | PROKR2 (0.74) | PROKR2MAPK8ACKR3 | |
| SCHEMBL10119922 | 0.88 | PROKR2 (0.71) | PROKR2MTNR1AMAPK8ROCK2ROCK1 | |
| SCHEMBL565184 | 0.88 | PROKR2 (0.71) | PROKR2MTNR1AMAPK8ROCK2ROCK1 | |
| SCHEMBL565130 | 0.88 | PROKR2 (0.73) | PROKR2MTNR1AMAPK8ACKR3 | |
| SCHEMBL565569 | 0.87 | PROKR2 (0.72) | PROKR2MTNR1AMAPK8MAP3K7TAB1 | |
| SCHEMBL565287 | 0.87 | PROKR2 (0.72) | PROKR2MAPK8 | |
| SCHEMBL565268 | 0.86 | PROKR2 (0.71) | PROKR2MAPK8CYP3A4CYP2C9ACKR3 | |
| SCHEMBL565032 | 0.86 | PROKR2 (0.71) | PROKR2MAPK8CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8722896-B2 | Prokineticin receptor antagonists and uses thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-05-13 | — | — | US | disclosed |
| US-20120035149-A1 | Prokineticin Receptor Antagonists And Uses Thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035149-A1 | Prokineticin Receptor Antagonists And Uses Thereof | PROKR2, PROKR1, GIPR | PROKR2 1/4885MTNR1A 130/4885MAPK8 1270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.